Open original FDA record ↗Recall record
- FDA identifier
- Z-1847-2013
- Company in FDA record
- Hospira Inc.
- FDA classification date
- Aug 1, 2013
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The devices secondary audio signal fails to activate.
Source facts
- Action
- Hospira sent a Urgent Device Field Correction letter dated February 4, 2013, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. In addition, letters were sent by e-mail to ECRI, NRAC, Noblis and ISMP for notification of their members and posting on their websites February 5, 2013. The letter was also posted on the Hospira website February 4, 2013. Customers were requested to return a reply form indicating they have received the letter and notified their users. For further inquiries please contact Hospira Global Complaint Management at 1-800-441-4100 ( 8am - 5pm CST, M-F) to report adverse events or product complaints, or Hospira Advanced Knowledge Center at 1-800-241-4002, option 4 for additional information or technical assistance. ( 24hrs a day / 7 days a week.
- Initiated
- 2013-02-04
- Root cause
- Process control
- Terminated
- 2016-11-07
- Distribution
- US Distribution including the states of AL, CA, CT, DE, FL, HI, IA, IL, IN, LA, MA, MD, ME, MI, MN, NC, NJ, NY, PA, SD, TX and WA.
- Recall number
- Z-1847-2013
- Recall status
- Terminated
- CDRH record ID
- 119733
- FDA classified
- 2013-08-01
- Recall event number
- 65610